en.unionpedia.org

Ludwig N. Hantson, the Glossary

Index Ludwig N. Hantson

Ludwig Norbert Michel Hantson (born August 1962) is a Belgium businessman, the CEO of Alexion Pharmaceuticals since March 2017.[1]

Table of Contents

  1. 5 relations: Alexion Pharmaceuticals, Baxalta, Baxter International, Shire (pharmaceutical company), UCLouvain.

  2. Belgian chief executives

Alexion Pharmaceuticals

Alexion Pharmaceuticals, a subsidiary of AstraZeneca, is a pharmaceutical company headquartered in Boston, Massachusetts that specializes in orphan drugs to treat rare diseases.

See Ludwig N. Hantson and Alexion Pharmaceuticals

Baxalta

Baxalta (Bax from the name of its former parent company; alta a Latin adjective meaning 'high' or 'profound') is a biopharmaceutical company founded on 1 July 2015 after its parent company, Baxter International, spun off biopharmaceutical division.

See Ludwig N. Hantson and Baxalta

Baxter International

Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.

See Ludwig N. Hantson and Baxter International

Shire (pharmaceutical company)

Shire plc was a UK-founded Jersey-registered specialty biopharmaceutical company.

See Ludwig N. Hantson and Shire (pharmaceutical company)

UCLouvain

UCLouvain (Université catholique de Louvain. also known as the Catholic University of Louvain, the English translation of its French name, and the University of Louvain, its official English name) is Belgium's largest French-speaking university.

See Ludwig N. Hantson and UCLouvain

See also

Belgian chief executives

References

[1] https://en.wikipedia.org/wiki/Ludwig_N._Hantson

Also known as Ludwig Hantson.